BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33907144)

  • 1. Primary vaginal malignant melanoma: A rare case report of successful treatment with nivolumab.
    Guo N; Zhang J
    Medicine (Baltimore); 2021 Apr; 100(17):e25691. PubMed ID: 33907144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary malignant melanoma of the uterine cervix or vagina which were successfully treated with nivolumab.
    Anko M; Nakamura M; Kobayashi Y; Tsuji K; Nakada S; Nakamura Y; Funakoshi T; Banno K; Aoki D
    J Obstet Gynaecol Res; 2020 Jan; 46(1):190-195. PubMed ID: 31608533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usage of nivolumab and ipilimumab for recurrent or advanced malignant vaginal melanoma: a two-case series.
    Konishi K; Okamoto M; Tokumitsu R; Yano M; Nasu K; Kobayashi E
    Med Mol Morphol; 2024 Jun; 57(2):83-90. PubMed ID: 38289480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Itraconazole treatment of primary malignant melanoma of the vagina evaluated using positron emission tomography and tissue cDNA microarray: a case report.
    Inoue K; Tsubamoto H; Isono-Nakata R; Sakata K; Nakagomi N
    BMC Cancer; 2018 Jun; 18(1):630. PubMed ID: 29866134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary malignant melanoma of vagina].
    Daix M; Dillies P; Gueuning A; Watkins-Masters L; Gielen F
    Rev Med Liege; 2018 Jul; 73(7-8):413-418. PubMed ID: 30113785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbon ion radiotherapy for vaginal malignant melanoma: a case report.
    Ohno T; Kato S; Sasaki E; Mizutani K; Tsujii H
    Int J Gynecol Cancer; 2007; 17(5):1163-6. PubMed ID: 17451456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary malignant melanoma of the esophagus successfully treated with nivolumab: a case report.
    Ito S; Tachimori Y; Terado Y; Sakon R; Narita K; Goto M
    J Med Case Rep; 2021 May; 15(1):237. PubMed ID: 33947459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary malignant vaginal melanoma treated with adriamycin and ifosfamide: a case report and literature review.
    Signorelli M; Lissoni AA; Garbi A; Perego P; Mangioni C
    Gynecol Oncol; 2005 May; 97(2):700-3. PubMed ID: 15863186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone.
    Afzal MZ; Mabaera R; Shirai K
    J Immunother Cancer; 2018 Feb; 6(1):13. PubMed ID: 29433557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nivolumab-induced colitis in a patient with malignant melanoma: A case report and immunological analysis.
    Miyashita A; Fukushima S; Tsukamoto H; Itai H; Miyamoto H; Nakahara S; Kubo Y; Kimura T; Kuriyama H; Ihn H
    J Dermatol; 2019 Sep; 46(9):e339-e341. PubMed ID: 30908699
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunotherapy combined with high- and low-dose radiation to all sites leads to complete clearance of disease in a patient with metastatic vaginal melanoma.
    Sezen D; Patel RR; Tang C; Onstad M; Nagarajan P; Patel SP; Welsh JW; Lin LL
    Gynecol Oncol; 2021 Jun; 161(3):645-652. PubMed ID: 33795130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of primary vaginal malignant melanoma and review of previous literature: A case report.
    Bai S; Wu Q; Song L; Wu W
    Medicine (Baltimore); 2023 Dec; 102(49):e36128. PubMed ID: 38065883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rare site of malignant melanoma].
    Baumann D; Böhme M; Donat H; Lenz E; Theuring U
    Zentralbl Gynakol; 1992; 114(12):609-12. PubMed ID: 1285486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nivolumab to pembrolizumab switch induced a durable melanoma response: A case report.
    Lepir T; Zaghouani M; Roche SP; Li YY; Suarez M; Irias MJ; Savaraj N
    Medicine (Baltimore); 2019 Jan; 98(2):e13804. PubMed ID: 30633154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary malignant melanoma of the vagina and treatment options: a case report].
    Tsvetkov Ch; Gorchev G; Tomov S; Hinkova N; Nikolova M; Veselinova T
    Akush Ginekol (Sofiia); 2014; 53(7):35-40. PubMed ID: 25679034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary malignant melanoma of the vagina: case report.
    Stellato G; Iodice F; Casella G; Fortuna G; Tramontana R; di Bonito M; Tramontana S
    Eur J Gynaecol Oncol; 1998; 19(2):186-8. PubMed ID: 9611064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary malignant melanoma of the vagina: a case report.
    Androutsopoulos G; Adonakis G; Ravazoula P; Kourounis G
    Eur J Gynaecol Oncol; 2005; 26(6):661-2. PubMed ID: 16398233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary malignant melanoma of the esophagus, treated with immunotherapy: a case report.
    Rochefort P; Roussel J; de la Fouchardière A; Sarabi M; Desseigne F; Guibert P; Cattey-Javouhey A; Mastier C; Neidhardt-Berard EM; de la Fouchardière C
    Immunotherapy; 2018 Aug; 10(10):831-835. PubMed ID: 30073896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary malignant melanoma of the vagina--case report and review of the literature].
    Betschart C; von Orelli S; Mihic D; Fink D
    Gynakol Geburtshilfliche Rundsch; 2007; 47(1):39-44. PubMed ID: 17272935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudo-Progression of Melanoma Treated with Nivolumab/Ipilimumab: A Case Report.
    Cuevas Velazquez AM; Ng WL; Calderón Martínez EJ; Yeruva SLH
    Am J Case Rep; 2023 Aug; 24():e940954. PubMed ID: 37545116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.